Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

C50

K-Number: K223470 · 2023-12-14

ApplicantSopro
Decision Date2023-12-14
Product CodeNBL
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

C50 is a medical device manufactured by Sopro. It received FDA 510(k) clearance on 2023-12-14 under approval number K223470. The device is classified under product code NBL. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the C50?

C50 is a medical device that received FDA 510(k) clearance on 2023-12-14. It is manufactured by Sopro. The 510(k) number is K223470.

When was C50 approved by the FDA?

C50 received FDA 510(k) clearance on 2023-12-14, under approval number K223470.

What company makes C50?

C50 is manufactured by Sopro.

What is the FDA product code for C50?

The FDA product code for C50 is NBL.

Related Clinical Trials

Related Devices (Code: NBL)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.